Clonazepam is a controlled substance in Kenya. It requires a prescription from a registered prescriber under the Narcotic Drugs and Psychotropic Substances Act.
What it treats
Which conditions is Clonazepam used for?
Overview
What is Clonazepam?
Clonazepam is a benzodiazepine medicine used primarily for epilepsy and for panic disorder. It acts more slowly than some other benzodiazepines and lasts longer in the body, which makes it useful for conditions needing sustained coverage.
It is listed in Kenya's Essential Medicines List 2023 and is available through prescription at Level 4 facilities and above.
Like all benzodiazepines, clonazepam is effective when used appropriately. For anxiety and panic disorder, use should be kept as short as possible, as the body adapts to the medicine over weeks and dependence can develop.
How it works
What does it do in the brain?
Formulations in Kenya
How is it available?
Availability across Africa
Where is it available in Africa and what is it called?
| Country | Common Brand Name(s) | Notes |
|---|---|---|
| Uganda | Rivotril, Clonazepam (generic) | Available at private pharmacies in Kampala and at Butabika Hospital for epilepsy. |
| South Africa | Rivotril, Clonazepam (generic) | Available in public and private sectors; used for epilepsy and panic disorder. |
| Nigeria | Rivotril, Klonopin | Available at teaching hospitals and private pharmacies in major cities. |
| Ghana | Clonazepam (generic) | Available at Korle-Bu and larger specialist pharmacies. |
| Tanzania | Clonazepam (generic) | Available at Muhimbili National Hospital for epilepsy management. |
| Ethiopia | Clonazepam (generic) | Available at major teaching hospitals in Addis Ababa. |
Side effects
What might you feel while taking it?
These are the most commonly reported effects. Not everyone experiences them, and many settle within the first few weeks.
- Drowsiness and sedation, particularly at the start of treatment
- Dizziness and unsteadiness
- Memory and concentration difficulties
- Muscle weakness
- Slowed reaction time. Do not drive or operate machinery
- Tolerance developing over time
- Dependence with use beyond a few weeks for anxiety
- Breathing difficulty, particularly if combined with alcohol, opioids, or other sedating medicines
- Paradoxical reactions, increased agitation in some people, particularly children and elderly
Who should not take it
Important warnings before starting
- Significant breathing problems or sleep apnoea
- Severe liver disease
- Myasthenia gravis
- History of hypersensitivity to benzodiazepines
Special care needed
Situations that need extra attention
- Do not combine with alcohol
- Do not drive until you know how the medicine affects you
- Elderly patients are particularly sensitive and have a higher fall and confusion risk
- For epilepsy, never stop clonazepam suddenly, seizures can occur
- For anxiety use, keep treatment as short as possible and discuss a reduction plan early
Benzodiazepines can affect the baby, particularly near delivery. Speak to your doctor before making any changes if you are pregnant or planning a pregnancy.
Passes into breast milk and can cause infant sedation. Not recommended during breastfeeding without specialist review.
Other medicines
Medicines and substances that can interact with it
- Alcohol and opioid pain medicines: A potentially dangerous combination that greatly increases sedation and the risk of breathing problems.
- Other sedating medicines: Sedative effects are amplified significantly.
- Carbamazepine and other enzyme-inducing anticonvulsants: May reduce clonazepam levels. Your doctor will adjust as needed.
Tests and follow-up
What your doctor will monitor
- Seizure frequency and control for epilepsy use, reviewed at every appointment
- Signs of tolerance or dependence, discussed openly with your doctor
- Duration of treatment for anxiety, short-term use only, with regular review
Stopping this medicine
What happens if you stop taking it?
In Kenya
What you should know about this medicine in Kenya
Clonazepam is available in Kenya at Level 4 and above and is a useful addition to the epilepsy treatment toolkit.
Its use for panic disorder fills an important gap in settings where access to psychological therapies for panic is limited. However, the goal should always be to use it as a bridge to longer-term treatment.
As with all benzodiazepines, awareness of dependence risk needs to improve to prevent long-term inappropriate use.
Sources
References
- Ministry of Health, Kenya. (2023). Kenya Essential Medicines List 2023. Nairobi: Ministry of Health.
- Ministry of Health, Kenya. (2023). Kenya National Medicines Formulary, 1st Edition. Nairobi: Ministry of Health.
- World Health Organization. (2023). Model List of Essential Medicines, 23rd Edition. Geneva: WHO.
- Government of Kenya. Narcotic Drugs and Psychotropic Substances Act (Cap 245).